Oxapex 25 100 tablets

Oxapex 25 (Oxandrolone 25mg) 100 Tablets | NexorinPharma

Oxapex 25 is an oral anabolic steroid containing 25mg of Oxandrolone per tablet. Each pack contains 100 tablets. At NexorinPharma, we carry Oxapex 25 as part of our oral anabolic steroid inventory for customers in markets where Oxandrolone is legally available.

Oxandrolone is one of the most clinically documented anabolic steroids available. Unlike most anabolic steroids discussed in performance communities, Oxandrolone carries active FDA approval for specific medical indications and has a well-established clinical research base spanning several decades.

The 25mg tablet format of Oxapex 25 represents a higher concentration presentation than the standard pharmaceutical grade Oxandrolone tablet formats of 2.5mg and 10mg. This distinction is relevant context for anyone researching this specific product.

Like all anabolic-androgenic steroids, Oxapex 25 carries significant health and legal considerations. This page covers what Oxandrolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage steroid use. It does not provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

Website: nexorinpharma.com Product Name: Oxapex 25 Active Compound: Oxandrolone Also Known As: Anavar, Var, Oxandrin Drug Class: Anabolic-androgenic steroid, 17-alpha alkylated oral steroid, DHT derivative Concentration: 25mg per tablet Pack Size: 100 tablets Presentation: Oral tablet Form: Tablet Half-Life: Approximately 9 to 10 hours Route of Administration: Oral Anabolic Rating: 322 to 630 relative to testosterone baseline of 100 Androgenic Rating: 24 relative to testosterone baseline of 100 Aromatization: None 17-Alpha Alkylated: Yes Liver Toxicity: Mild to moderate Legal Status: Schedule III controlled substance in the United States. Prescription required. Legal status varies by country.

What Is Oxandrolone

Oxandrolone is a synthetic anabolic-androgenic steroid derived from Dihydrotestosterone. Searle Laboratories developed it in 1962 and introduced it to the US market under the brand name Anavar in 1964. From the beginning, it was developed with a specific goal in mind: produce a compound with strong anabolic activity and minimal androgenic effects.

Structurally, Oxandrolone is a modified form of DHT. Two key structural modifications define it. First, a methyl group at the 17-alpha position allows it to survive first-pass liver metabolism when taken orally. Second, an oxygen atom replaces the carbon-2 atom in the A-ring of the steroid structure. This second modification is directly responsible for Oxandrolone’s unusually high anabolic-to-androgenic ratio and its resistance to aromatization.

Together, these modifications produce an oral anabolic steroid with an anabolic rating of 322 to 630 and an androgenic rating of only 24 relative to a testosterone baseline of 100. Strong anabolic activity combined with very low androgenic potency and no estrogenic conversion defines its pharmacological profile entirely.

How Oxandrolone Works

Oxandrolone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.

Androgen Receptor Binding

Oxandrolone binds to androgen receptors throughout the body. Its androgenic activity is significantly lower than testosterone despite its high anabolic rating. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively minimal androgenic activity in androgen-sensitive tissues like skin and hair follicles.

Nitrogen Retention

Oxandrolone produces positive nitrogen retention in muscle tissue. The body retains more nitrogen than it excretes. As a result, this supports an anabolic environment that favors muscle repair and preservation. This mechanism is particularly relevant in clinical contexts where muscle wasting prevention is a primary treatment goal.

Protein Synthesis

Oxandrolone accelerates protein synthesis in skeletal muscle tissue. Faster protein synthesis supports muscle repair and growth following training or tissue stress. This mechanism is directly tied to its anabolic receptor activity and contributes to its documented clinical efficacy across multiple indications.

No Aromatization

Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects including water retention and gynecomastia are not part of its direct pharmacological profile. This characteristic distinguishes Oxandrolone from testosterone and many other anabolic steroids where estrogenic conversion is a primary side effect consideration.

IGF-1 Stimulation

Oxandrolone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism contributes to the muscle preservation and recovery effects documented across Oxandrolone’s clinical research base.

Creatine Phosphate Synthesis

Oxandrolone enhances creatine phosphate synthesis in muscle tissue. Creatine phosphate is a primary energy substrate for high-intensity muscular activity. As a result, enhanced creatine phosphate availability supports strength and power output during physical activity.

Clinical Background

Oxandrolone carries a more extensive clinical history than virtually any other anabolic steroid discussed in performance communities. This clinical background provides important context for its pharmacological profile and documented effects.

FDA Approval and Current Indications

The FDA approved Oxandrolone under the brand name Oxandrin, currently produced by Savient Pharmaceuticals. Unlike most anabolic steroids, Oxandrolone retains active FDA approval today. Its current approved indications include weight regain following involuntary weight loss associated with surgery, chronic infection, trauma, or prolonged corticosteroid use. It is also approved for the treatment of bone pain associated with osteoporosis.

HIV and AIDS-Related Muscle Wasting

Oxandrolone has extensive clinical research documentation in the treatment of HIV and AIDS-related muscle wasting. Multiple controlled clinical trials document its efficacy in preserving and restoring lean body mass in HIV-positive patients experiencing involuntary weight loss. This clinical application represents one of the most well-documented uses of any anabolic steroid in modern medical research.

Burns and Wound Healing

Clinical research documents Oxandrolone’s efficacy in accelerating recovery and preserving lean body mass in severe burn patients. Studies in both pediatric and adult burn patients demonstrate meaningful improvements in recovery outcomes with Oxandrolone use under medical supervision. As a result, burn treatment represents one of its most consistently supported clinical applications.

Turner Syndrome

Researchers have studied and used Oxandrolone clinically in girls with Turner syndrome to promote linear growth. This pediatric application reflects its documented low androgenic activity and relative safety profile compared to other anabolic steroids at appropriate clinical doses.

Alcoholic Hepatitis

Clinical research has examined Oxandrolone in the treatment of alcoholic hepatitis. Its anabolic properties and relatively mild liver impact compared to other oral anabolic steroids make it a relevant research compound in this context. This represents a distinct clinical application outside of muscle wasting and growth indications entirely.

About the 25mg Concentration

The 25mg per tablet concentration of Oxapex 25 exceeds the standard pharmaceutical clinical tablet formats for Oxandrolone. Understanding this distinction is important context for anyone researching this specific product.

Comparison With Standard Clinical Formats

The FDA-approved Oxandrin product is available in 2.5mg and 10mg tablet formats. Oxapex 25 contains 25mg of Oxandrolone per tablet, which is 2.5 times the concentration of the maximum standard pharmaceutical tablet format. This higher concentration per tablet carries additional side effect considerations compared to standard clinical dose formats.

Non-Prescription Market Context

Higher concentration Oxandrolone tablet formats including 25mg, 40mg, and 50mg are produced by various manufacturers in non-prescription markets. Oxapex 25 sits within the lower range of these higher concentration non-prescription formats. As a result, it represents a middle ground between standard clinical concentrations and the highest concentration non-prescription formats available.

Pack Size Context

The 100 tablet pack size of Oxapex 25 is a standard non-prescription market format. This pack size provides a larger quantity per purchase than standard pharmaceutical prescription formats and is a common presentation across non-prescription oral anabolic steroid products.

Oxapex 25 Versus Other Oxandrolone Products and Oral Anabolic Steroids

Versus Osteovar Oxandrolone 10mg USP

Osteovar Oxandrolone 10mg USP contains the same active compound as Oxapex 25 at a lower concentration per tablet. The USP designation on Osteovar indicates compliance with United States Pharmacopeia standards for compound identity and purity. Oxapex 25 provides a higher concentration per tablet at 25mg, which offers different practical considerations compared to the 10mg USP format.

Versus Methandrostenolone (Dianabol)

Methandrostenolone is a 17-alpha alkylated oral anabolic steroid that aromatizes significantly to estrogen. It carries significant liver toxicity, pronounced estrogenic side effects, and a more aggressive overall side effect profile. Oxapex 25, on the other hand, produces no estrogenic conversion, lower liver stress, and significantly lower androgenic activity. As a result, Oxandrolone represents a considerably milder pharmacological profile than Methandrostenolone across virtually all side effect parameters.

Versus Oxymetholone (Anadrol)

Oxymetholone is one of the most potent oral anabolic steroids available. It carries significant liver toxicity and pronounced estrogenic effects despite not directly aromatizing. Compared to Oxymetholone, Oxapex 25 produces dramatically lower liver stress, no estrogenic conversion, and a significantly more favorable side effect profile overall.

Versus Stanozolol (Winstrol)

Stanozolol is a non-aromatizing oral anabolic steroid and fellow DHT derivative. Both compounds do not convert to estrogen. However, Stanozolol carries more significant liver toxicity and more pronounced adverse lipid effects than Oxandrolone. In addition, Stanozolol’s androgenic activity exceeds Oxandrolone’s very low androgenic rating of 24. Oxapex 25 consequently represents a milder profile than Stanozolol across liver and androgenic side effect parameters.

Versus Turinabol

Turinabol is a non-aromatizing oral anabolic steroid with a moderate anabolic profile. Both Turinabol and Oxandrolone are non-aromatizing oral compounds. However, Oxandrolone carries active FDA approval and a more extensive clinical research base than Turinabol. Furthermore, Oxandrolone’s anabolic rating significantly exceeds Turinabol’s more moderate anabolic activity.

Side Effects and Health Risks

Oxapex 25 carries a side effect profile that is generally considered milder than most oral anabolic steroids. These risks remain real and should not be minimized.

Liver Toxicity

Oxandrolone is a 17-alpha alkylated oral steroid. The alkylation that allows oral bioavailability places stress on liver tissue. However, Oxandrolone’s liver toxicity is consistently documented as milder than other 17-alpha alkylated oral anabolic steroids including Methandrostenolone, Stanozolol, and Oxymetholone. Elevated liver enzymes are possible with Oxandrolone use. Therefore, liver monitoring through regular blood work remains a relevant health consideration despite its comparatively mild hepatotoxicity profile.

Cardiovascular Effects

Oxandrolone produces adverse lipid profile changes. HDL cholesterol decreases while LDL cholesterol increases. These lipid changes carry long-term cardiovascular health implications. In addition, the higher 25mg concentration per tablet compared to standard clinical formats increases the relevance of cardiovascular monitoring. Regular lipid monitoring is therefore important for anyone using this compound.

Androgenic Effects

Despite its very low androgenic rating of 24, Oxandrolone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne. In women, virilization risks including voice deepening and clitoral enlargement are serious considerations even at lower doses given Oxandrolone’s anabolic potency.

Hormonal Suppression

Oxandrolone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. The degree of suppression is generally considered less pronounced than with more potent anabolic steroids. However, post-use hormonal disruption remains a relevant consideration. In some cases, it results in hypogonadism requiring medical treatment.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Oxandrolone use. They are generally less pronounced than with higher androgenic compounds but remain relevant health considerations nonetheless.

Legal and Regulatory Status

Oxandrolone retains active FDA approval under the brand name Oxandrin for specific clinical indications. Outside of those indications, however, it carries Schedule III controlled substance status in the United States. Possession without a valid prescription is a federal offense.

In the United Kingdom, Oxandrolone falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Oxandrolone alongside all major athletic governing bodies. It consequently appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Oxandrolone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Oxapex 25 Available at NexorinPharma

Yes. NexorinPharma carries Oxapex 25 for customers in markets where Oxandrolone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Oxandrolone

Oxandrolone produces a half-life of approximately 9 to 10 hours. As a result, active plasma concentrations are sustained longer than shorter half-life oral anabolic steroids while still requiring regular oral administration to maintain stable levels.

Does Oxandrolone Aromatize

No. Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects are not part of its direct pharmacological profile.

How Does the 25mg Concentration Compare to Standard Clinical Oxandrolone Formats

The FDA-approved Oxandrin product is available in 2.5mg and 10mg tablet formats. The 25mg concentration of Oxapex 25 consequently exceeds the maximum standard pharmaceutical tablet format by 2.5 times. This higher concentration per tablet carries additional side effect considerations compared to standard clinical formats.

What Are the Most Serious Health Risks

Cardiovascular effects from lipid dysregulation are among the most clinically significant concerns with Oxandrolone. In addition, hormonal suppression, androgenic effects, and liver enzyme elevation complete the primary risk profile. Medical supervision and regular blood work monitoring are therefore essential for anyone using this compound.

Is Oxapex 25 Legal to Purchase

Oxandrolone carries Schedule III controlled substance status in the United States and requires a valid prescription despite retaining active FDA approval for specific indications. Legal status varies by jurisdiction. You are responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Oxapex 25

Oxandrolone has one of the most extensive clinical research bases of any anabolic steroid discussed in performance communities. Its active FDA approval, documented clinical applications across multiple indications, and decades of controlled clinical trial data provide a substantially stronger research foundation than most anabolic steroids carry.

The 25mg concentration of Oxapex 25 exceeds standard clinical tablet formats. As a result, the side effect considerations associated with higher Oxandrolone concentrations are more relevant to this specific product than to standard clinical dose formats. The clinical research base for Oxandrolone at standard doses provides a relevant pharmacological framework. However, it does not fully represent the risk profile at the 25mg concentration outside of clinical supervision.

Oxandrolone carries documented cardiovascular, liver, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Regular blood work monitoring including liver enzymes, lipid panels, and hormone levels is therefore essential for anyone using this compound.

For customers in markets where Oxandrolone is legally available, visit nexorinpharma.com to check current Oxapex 25 availability, pricing, and stock levels.